Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the recurrence rate following total clearance of
external genital warts (EGWs) when clearance has been obtained by imiquimod (3 applications
per week for 4 weeks) followed by ablative therapy (laser or electrocautery therapy) with
that from just ablative therapy treatment alone.